Geode Capital Management
AUGX

Geode Capital Management’s Augmedix, Inc. Common Stock AUGX Stock Holding History

Geode Capital Management’s Portfolio AUGX Stock Details AUGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-556,611
Closed -$1.31M – 4592
2024
Q3 		$1.31M Buy
556,611
+58,175
+12% +$117K ﹤0.01% 3255
2024
Q2 		$439K Buy
498,436
+67,671
+16% +$140K ﹤0.01% 3610
2024
Q1 		$1.76M Buy
430,765
+69,150
+19% +$309K ﹤0.01% 3161
2023
Q4 		$2.12M Buy
361,615
+21,723
+6% +$114K ﹤0.01% 3082
2023
Q3 		$1.75M Buy
339,892
+67,395
+25% +$316K ﹤0.01% 3115
2023
Q2 		$1.31M Buy
272,497
+61,976
+29% +$214K ﹤0.01% 3252
2023
Q1 		$366K Hold
210,521
– – ﹤0.01% 3772
2022
Q4 		$328K Sell
210,521
-419
-0.2% -$534 ﹤0.01% 3853
2022
Q3 		$305K Buy
210,940
+96,058
+84% +$165K ﹤0.01% 3980
2022
Q2 		$206K Buy
114,882
+2,179
+2% +$5.04K ﹤0.01% 4246
2022
Q1 		$331K Buy
112,703
+4,049
+4% +$11K ﹤0.01% 4138
2021
Q4 		$342K Buy
+108,654
New +$394K ﹤0.01% 4231

Geode Capital Management's AUGX Position: Q4 2024 in Review

Geode Capital Management sold out of Augmedix, Inc. Common Stock (AUGX) in Q4 2024, closing a stake of 556,611 shares — an estimated $1.31M sold.

Geode Capital Management first reported a position in AUGX in Q4 2021 and held it in 12 quarters. The position peaked at $2.12M in Q4 2023. 0 funds tracked by Wall St. Rank hold AUGX as of Q4 2024.

  • Geode Capital Management reported no remaining Augmedix, Inc. Common Stock position as of Q4 2024 after selling out during the quarter.
  • Geode Capital Management sold 556,611 Augmedix, Inc. Common Stock shares in Q4 2024, an estimated $1.31M.
  • Geode Capital Management first reported a position in Augmedix, Inc. Common Stock in Q4 2021 and held it in 12 quarters.
  • Geode Capital Management's Augmedix, Inc. Common Stock position peaked at $2.12M in Q4 2023.
  • 0 funds tracked by Wall St. Rank held Augmedix, Inc. Common Stock as of Q4 2024.

Based on Geode Capital Management's 13F filing for Q4 2024, filed 12 Feb 2025.